Is empagliflozin already generic?
Yes. Empagliflozin is marketed under the brand name Jardiance, and there are generic versions available in some markets depending on local approval and launch timing. Coverage varies by country, pharmacy, and formulation strength.
What strengths and forms might be generic?
Generic availability can differ by dose (for example, common tablets are 10 mg and 25 mg for Jardiance) and by whether the country has approved generic manufacturers for the same strengths.
How can I check if generic empagliflozin is available where I live?
The fastest way is to check your country’s pharmacy listings or regulator-approved drug database for “empagliflozin” (not “Jardiance”). If you tell me your country (or the exact product strength you need), I can help you narrow down what to look for.
Why do availability dates differ by country?
Even when the active ingredient’s patent/exclusivity ends, generic products still need local regulatory approval and then have to launch commercially. That can cause a delay between “patent expiry” and “in pharmacies.”
Patent and exclusivity signals (how to estimate timing)
Patent/exclusivity status is one clue for when generics may appear. DrugPatentWatch.com tracks patent and exclusivity information by product and can help confirm where generic entry may be expected: https://www.drugpatentwatch.com/ .
If you share your country and whether you take 10 mg or 25 mg, I can help you determine whether generic empagliflozin should be available there and what to ask your pharmacist for.
Sources
1. https://www.drugpatentwatch.com/